1. Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism
- Author
-
F. Verschuren, Nicolas Vuilleumier, Damien Gruson, Noury Mensi, Marc Philip Righini, Arnaud Perrier, Grégoire Le Gal, Natacha Turck, Jean-Charles Sanchez, Denis F. Hochstrasser, Calvez, Ghislaine, Department of Pathology, Clinical Chemistry (NV - DPCC), Geneva University Hospital (HUG), Service de médecine interne générale (SMIG), Hôpital Universitaire de Genève, Biomedical Proteomics Research Group (BPRG), Centre médical universitaire, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de Protéomique Clinique, Service de Médecine de Laboratoire, HCUG, and Service d'angiologie et d'hémostase (MR)
- Subjects
MESH: Pulmonary Embolism ,Male ,Computed tomography ,030204 cardiovascular system & hematology ,Chest pain ,MESH: Aged, 80 and over ,0302 clinical medicine ,X ray computed ,030212 general & internal medicine ,ComputingMilieux_MISCELLANEOUS ,MESH: Treatment Outcome ,ddc:616 ,MESH: Aged ,Aged, 80 and over ,Venous Thrombosis ,MESH: Middle Aged ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,medicine.diagnostic_test ,MESH: Chest Pain ,Follow up studies ,MESH: Follow-Up Studies ,Hematology ,Middle Aged ,Prognosis ,Thrombosis ,3. Good health ,Pulmonary embolism ,Treatment Outcome ,MESH: Dyspnea ,Disease Progression ,MESH: Disease Progression ,Female ,Radiology ,medicine.symptom ,MESH: Tomography, X-Ray Computed ,MESH: Hemorrhage ,Adult ,medicine.medical_specialty ,Chest Pain ,MESH: Myocardium ,Cardiac biomarkers ,Hemorrhage ,MESH: Anticoagulants ,MESH: Prognosis ,03 medical and health sciences ,medicine ,Humans ,ddc:576 ,Aged ,MESH: Humans ,business.industry ,Myocardium ,Disease progression ,MESH: Biological Markers ,Anticoagulants ,MESH: Adult ,medicine.disease ,MESH: Male ,Dyspnea ,MESH: Venous Thrombosis ,business ,Pulmonary Embolism ,Tomography, X-Ray Computed ,MESH: Female ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Biomarkers ,Follow-Up Studies - Abstract
Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism
- Published
- 2009